EDGAR Filing Documents for 0001179110-16-029619

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001179110-16-029619

Filing Date

2016-09-13

Accepted

2016-09-13 17:24:54

Documents

Period of Report

2016-09-08

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4/A -	edgar.html	4/A
1	FORM 4/A -	edgar.xml	4/A	4387
	Complete submission text file	0001179110-16-029619.txt		5837

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CAMBRIDGE MA 02139

Business Address

Type: 4/A | Act: 34 | File No.: 001-37467 | Film No.: 161883536